Inhibikase Therapeutics Inc
About
Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in developing protein kinase inhibitor therapeutics to modify the course of Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases.
It also focuses on neurodegeneration and its lead program IkT-148009, an Abelson Tyrosine Kinase (c-Abl) inhibitor, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Ableson Tyrosine Kinases. The company was founded by Milton H. Werner in September 2008 and is headquartered in Atlanta, GA.
Growth
Inhibikase Therapeutics, Inc. is a pharmaceutical company currently in the scale-up stage. The company has been steadily growing its pipeline of novel small-molecule kinase inhibitor therapeutics targeting Parkinson's disease and related neurodegenerative diseases. With recent significant financial investments and advancements into late-stage clinical trials for treatments like IkT-001Pro, Inhibikase is demonstrating a strong growth trajectory in the biopharmaceutical industry.
Achievements
Inhibikase Therapeutics has achieved significant milestones in its history, such as securing up to $275 million in financing for its drug development programs and advancing IkT-001Pro into late-stage clinical trials for pulmonary arterial hypertension. The company's focus on innovative disease-modifying strategies for Parkinson's disease has garnered attention and support from investors, highlighting its commitment to developing impactful treatments for patients in need.
Case Studies
Inhibikase Therapeutics has been involved in several noteworthy case studies, including the development of IkT-001Pro, an optimized prodrug of Imatinib, for the treatment of pulmonary arterial hypertension. The company's RAMP™ drug innovation and prodrug technology engines have enabled the creation of novel treatments that show promise in halting or reversing the effects of neurodegenerative diseases. These case studies demonstrate the company's commitment to pioneering new approaches to disease management.
Key Events
Key events for Inhibikase Therapeutics have included the closing of major financing rounds totaling $385 million to support the advancement of their drug candidates. The company announced the pricing of a $110 million private placement to accelerate the development of IkT-001Pro into late-stage trials, underscoring their commitment to bringing innovative therapies to market. Additionally, the company's stock performance on Nasdaq (IKT) has shown significant growth, reflecting investor confidence in their pipeline and strategic initiatives.
Socials
Website
Founded
-
Operating Status
Active
Industry
Health Care/Life Sciences
headquarters
Address
3350 Riverwood Parkway South East Suite 1900 Atlanta Georgia 30339 United States...
Country
Georgia
Employees
6
Key People
Dennis N. Berman (Independent Director)
Roy Freeman (Independent Director)
Garth Lees-Rolfe (Chief Financial Officer)
C. Warren Olanow (Chief Medical Officer)
Revenue
123,440
Operating Income
Stock Price
$2.42
Why Setting Up a Virtual Delivery Center (VDC) Is Critical for Your Company’s Success
Achieving business success in today’s competitive landscape requires specialized expertise, seamless operations, and continuous innovation. Establishing a Virtual Delivery Center (VDC) can transform your company’s growth journey by ensuring efficiency, scalability, and long-term value.
Why Choose a VDC for Your Company?
1. Cost Optimization:
Save up to 70% on operational costs by leveraging remote teams and streamlined processes.
2. Expert Access:
Gain instant access to highly skilled professionals, ensuring faster and smoother project execution.
3. Scalable Teams:
Scale your team as business needs evolve, from initial project setup to long-term support.
4. Accelerated Timelines:
Leverage 24/7 global teams to reduce project delays and speed up implementation.
5. Continuous Support:
Ensure uninterrupted business performance with ongoing maintenance and updates.
Unlock Business Success with a VDC By establishing a VDC, your company can overcome operational challenges, achieve seamless system integration, and maximize ROI. Stay ahead in today’s dynamic market with a future-ready business strategy powered by a Virtual Delivery Center. Learn More About Us
Book A Meeting To Setup Your VDC
Similar Companies
Welcome to AiDOOS Wiki
AiDOOS Information Wiki provides comprehensive information about products, companies, and individuals.
Inhibikase Therapeutics Inc
-
Website
-
Founded
-
-
Industry
Health Care/Life Sciences
-
Address
3350 Riverwood Parkway South East Suite 1900 Atlanta Georgia 30339 United States...
-
Country
Georgia
-
Number of employees
6+
-
Revenue
123,440
About Inhibikase Therapeutics Inc
Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in developing protein kinase inhibitor therapeutics to modify the course of Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases.
It also focuses on neurodegeneration and its lead program IkT-148009, an Abelson Tyrosine Kinase (c-Abl) inhibitor, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Ableson Tyrosine Kinases. The company was founded by Milton H. Werner in September 2008 and is headquartered in Atlanta, GA.
Why Setting Up a Virtual Delivery Center (VDC) Is Critical for Your Company’s Success
Achieving business success in today’s competitive landscape requires specialized expertise, seamless operations, and continuous innovation. Establishing a Virtual Delivery Center (VDC) can transform your company’s growth journey by ensuring efficiency, scalability, and long-term value.
Why Choose a VDC for Your Company?
1. Cost Optimization:
Save up to 70% on operational costs by leveraging remote teams and streamlined processes.
2. Expert Access:
Gain instant access to highly skilled professionals, ensuring faster and smoother project execution.
3. Scalable Teams:
Scale your team as business needs evolve, from initial project setup to long-term support.
4. Accelerated Timelines:
Leverage 24/7 global teams to reduce project delays and speed up implementation.
5. Continuous Support:
Ensure uninterrupted business performance with ongoing maintenance and updates.
Unlock Business Success with a VDC By establishing a VDC, your company can overcome operational challenges, achieve seamless system integration, and maximize ROI. Stay ahead in today’s dynamic market with a future-ready business strategy powered by a Virtual Delivery Center. Learn More About Us
Book A Meeting To Setup Your VDC
